Literature DB >> 11270589

Obesity and autonomic function in adolescence.

P Riva1, G Martini, F Rabbia, A Milan, C Paglieri, L Chiandussi, F Veglio.   

Abstract

Hypertension and obesity are risk factors for coronary heart diseases in adults. In turn, childhood overweight and high blood pressure increase the risk of subsequent obesity and hypertension in adulthood. Human obesity is characterized by profound alterations of hemodynamic and metabolic states. Whether these alterations involve sympathetic nervous system control on cardiac function is controversial. We report the results of our study, conducted in a sample of obese adolescents by using power spectral analysis of heart rate variability. An increase in sympathetic tone coupled with a reduction in vagal tone was found. This allowed us to hypothesize that autonomic nervous system changes depend on the time course of obesity development. It is still unclear if treatment of obesity in adolescence prevents subsequent autonomic imbalance and hypertension.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11270589     DOI: 10.1081/ceh-100001197

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  20 in total

Review 1.  Microvascular disease in children and adolescents with type 1 diabetes and obesity.

Authors:  M Loredana Marcovecchio; Francesco Chiarelli
Journal:  Pediatr Nephrol       Date:  2010-08-19       Impact factor: 3.714

Review 2.  Novel Invasive and Noninvasive Cardiac-Specific Biomarkers in Obesity and Cardiovascular Diseases.

Authors:  Rajesh Parsanathan; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2019-10-16       Impact factor: 1.894

3.  Deficiency of bone morphogenetic protein-3b induces metabolic syndrome and increases adipogenesis.

Authors:  Íngrid Martí-Pàmies; Robrecht Thoonen; Patrick Seale; Alexia Vite; Alex Caplan; Jesus Tamez; Lauren Graves; Wei Han; Emmanuel S Buys; Donald B Bloch; Marielle Scherrer-Crosbie
Journal:  Am J Physiol Endocrinol Metab       Date:  2020-06-30       Impact factor: 4.310

4.  Sympathetic Activity Assessed during Exercise Recovery in Young Obese Females.

Authors:  R Lee Franco; Stacey H Privett; Mary K Bowen; Edmund O Acevedo; James A Arrowood; Edmond P Wickham; Ronald K Evans
Journal:  J Pediatr       Date:  2015-05-23       Impact factor: 4.406

5.  "Broken" autonomic cardiac circadian clock in obese adolescents: evidence and implications.

Authors:  Guido Grassi
Journal:  Clin Auton Res       Date:  2014-11-01       Impact factor: 4.435

6.  Childhood obesity and autonomic dysfunction: risk for cardiac morbidity and mortality.

Authors:  Duanping Liao; Sol M Rodríguez-Colón; Fan He; Edward O Bixler
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-10

7.  Metabolic syndrome burden in apparently healthy adolescents is adversely associated with cardiac autonomic modulation--Penn State Children Cohort.

Authors:  Sol M Rodríguez-Colón; Fan He; Edward O Bixler; Julio Fernandez-Mendoza; Alexandros N Vgontzas; Susan Calhoun; Zhi-Jie Zheng; Duanping Liao
Journal:  Metabolism       Date:  2015-02-03       Impact factor: 8.694

8.  Impaired cardiac autonomic nervous system function is associated with pediatric hypertension independent of adiposity.

Authors:  Justin R Ryder; Michael O'Connell; Tyler A Bosch; Lisa Chow; Kyle D Rudser; Donald R Dengel; Claudia K Fox; Julia Steinberger; Aaron S Kelly
Journal:  Pediatr Res       Date:  2015-09-21       Impact factor: 3.756

9.  Autonomic dysfunction: a possible pathophysiological pathway underlying the association between sleep and obesity in children at-risk for obesity.

Authors:  Denise C Jarrin; Jennifer J McGrath; Paul Poirier
Journal:  J Youth Adolesc       Date:  2014-12-06

10.  Analysis of cardiac autonomic modulation in obese and eutrophic children.

Authors:  Luiz Carlos Marques Vanderlei; Carlos Marcelo Pastre; Ismael Forte Freitas Júnior; Moacir Fernandes de Godoy
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.